Extension of the last date for filing statutory forms prescribed under DPCO, 2013
For the quarter ending September ‘2022 and Dec 2022, Form III can be filed up to February 15, 2023. For any MRP revision done between August 01, 2022, and January 31, 2023, Form V can be filed on February 15, 2023.
CDSCO issues notice on registration of medical device testing laboratories
The Central Drugs Standard Control Organisation has issued a notice on registration of medical devices as per Medical Device Rules (MDR) 2017. Medical Device Testing Laboratories are to be registered in form MD-40 for Testing of Medical Devices on behalf of the manufacturer.
Revised prices for medical devices to commence on 31.03.2022
Revised prices for medical devices to commence on 31.03.2022 instead of 30 December, 2022.
CDSCO and State Drugs Control Administration commence joint inspection of Drug Manufacturing Units
The Joint Inspections are being conducted all over the country as per the Standard Operating Procedures. A committee of two Joint Drugs Controllers has been constituted at CDSCO (HQ) to monitor the process of inspection, reporting & subsequent action so as to ensure compliance to the Drugs & Cosmetics Act, 1940 and Rules thereunder. The aim is to ensure high standards of quality compliance with respect to drugs manufactured in the country.
Pharmacy Council issues a Circular on compliance of conditions for pharmacist registration
The Pharmacy Council of India has issued a circular that seeks to further the interests of the pharmacists in India by facilitating them to work across the country. It has been decided that State Pharmacy Councils shall expediate registration cases involving transfer of registration of pharmacists.
Advisory on Impending Covid Outbreak
Face masks are to be used in all public places and Social distancing is to be maintained. Public gatherings like marriages, political or social meetings, etc. to be avoided.
Narcotic Drugs and Psychotropic Substances (Seizure, Storage, Sampling and Disposal) Rules, 2022
The process of Seizure, sampling, disposal and Storage of seized material is provided in the rules.
Incentives of up to Rs. 4 crores to hospitals, labs and digital health solution providers
The National Health Authority (NHA) has announced a Digital Health Incentive Scheme (DHIS) for the stakeholders of the digital health ecosystem. The incentives under this scheme would be provided to hospitals and diagnostic labs and also to the providers of digital health solutions such as Hospital/ Health Management Information System (HMIS) and Laboratory Management Information System (LMIS).
The PCI issues notice for Effective Management of the Appeal Process for the 2022- 23 Academic Session
The Pharmacy Council of India (PCI) has issued a notice of the decisions taken by its 384th Executive Committee. The notice elucidates that the decisions are being reflected on the Council’s website. All institutions seeking to appeal the committee’s decision shall submit compliance or representation on or before 21st December, 2022.
NMC Invites Comments on the proposed draft for inclusion of Aadhar Enabled Biometric Attendance System (AEBAS) in Medical Colleges
The proposed amendment seeks to compulsorily implement an Aadhar Enabled Biometric Attendance System (AEBAS) of National Information Centre (NIC). It will be applicable to faculties, tutors, demonstrators and senior residents. The propsed amendment also states that in the absence of AEBAS, renewals, recognition or continuation thereof, increase in seats, establishment of new medical colleges or new PG course will not be permitted.
